Safety concerns for the use of these vectors in humans will represent a significant challenge to clinical development
Safety concerns for the use of these vectors in humans will represent a significant challenge to clinical development. Broadly neutralizing antibody Immunogens that elicit bNAb remain a high priority. ideas…